Searchable abstracts of presentations at key conferences in endocrinology

ea0035p882 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Comparison of the effectiveness of bromocriptine and cabergoline treatment of microprolactinomas in women based on results of dynamic pituitary gland MRI

Kushnir Liudmila , Zabarovskaya Zoya

Objective: The aim was to compare the effectiveness of the bromocriptine and cabergoline treatment of the women with microprolactinomas.Materials and methods: 82 women with microprolactinomas were included in this study (51 patients received bromocriptine (Group 1) and 31 – cabergoline (Group 2)) with MRI-control after the first year of treatment (11 women from Group 1; 7 – from Group 2), the second (27 women from Group 1; 15 – from Group ...